苯并唑类的药理性质。I. 结构与麻痹作用之间的关系。 - Suppr

Suppr

超能文献

Pharmacological properties of benzazoles. I. Relationship between structure and paralyzing action.

作者信息

DOMINO E F, UNNA K R, KERWIN J

出版信息

J Pharmacol Exp Ther. 1952 Aug;105(4):486-97.

PMID:14955779

Abstract

摘要

相似文献

Pharmacological properties of benzazoles. I. Relationship between structure and paralyzing action.苯并唑类的药理性质。I. 结构与麻痹作用之间的关系。

J Pharmacol Exp Ther. 1952 Aug;105(4):486-97.

[Antagonistic action of thiamine towards the muscle paralyzing effects of acetylcholinomimetic curare simulants].[硫胺素对拟乙酰胆碱箭毒模拟物所致肌肉麻痹作用的拮抗作用]

C R Hebd Seances Acad Sci. 1955 Aug 1;241(5):530-2.

[Antagonistic action of thiamine-bound substances on the muscle-paralyzing effects of various acetylcholinomimetic curare-like substances].[硫胺结合物质对各种拟乙酰胆碱类箭毒样物质肌肉麻痹作用的拮抗作用]

C R Hebd Seances Acad Sci. 1956 Jan 4;242(1):195-7.

Effects of frequency of stimulation on the paralyzing dose of neuromuscular blocking agents.刺激频率对神经肌肉阻滞剂麻痹剂量的影响。

J Pharmacol Exp Ther. 1953 Feb;107(2):165-71.

Monoquaternary muscle paralyzing agents. II. Synthesis of N-(omega-phthalimidoalkyl)-N-alkyl-morpholinium iodides.单季铵类肌肉麻痹剂。II. N-（ω-邻苯二甲酰亚胺基烷基）-N-烷基吗啉鎓碘化物的合成。

J Med Pharm Chem. 1961 May 18;3:611-4. doi: 10.1021/jm50016a018.

[Experimental studies on modifying capacity of largactil in paralyzing effect of curare].[关于氯普马嗪对箭毒麻痹作用的影响的实验研究]

Riv Sper Freniatr Med Leg Alien Ment. 1955 Dec 31;79(4):859-64.

[Antagonism of thiamine and substances of the same group in relation to the muscular paralyzing effect of acetylcholinomimetic curarizing substances].[硫胺素及同组物质对拟乙酰胆碱箭毒样物质肌肉麻痹作用的拮抗作用]

Dan Tidsskr Farm. 1956 Sep 22;30(Suppl 2):65-8.

Relationship between the pharmacological action of neuromuscular drugs and their capacity to inhibit esterases.神经肌肉药物的药理作用与其抑制酯酶能力之间的关系。

Acta Physiol Pharmacol Neerl. 1955 Aug;4(2):187-200.

[Pharmacological classification of muscle relaxants and their antagonists].[肌肉松弛剂及其拮抗剂的药理学分类]

Cah Anesthesiol. 1961 Jul;8:753-77.

Phloroglucinol: a pharmacological reevaluation. I. Smooth muscle relaxing properties.间苯三酚：药理学再评价。I. 平滑肌舒张特性。

Arch Int Pharmacodyn Ther. 1962 Jul 1;138:311-9.

引用本文的文献

Developing Novel Therapies for Degenerative Cervical Myelopathy [AO Spine RECODE-DCM Research Priority Number 7]: Opportunities From Restorative Neurobiology.开发退行性颈椎脊髓病的新型疗法[AO脊柱RECODE-DCM研究优先级第7号]：来自修复性神经生物学的机遇

Global Spine J. 2022 Feb;12(1_suppl):109S-121S. doi: 10.1177/21925682211052920.

From Riluzole to Dexpramipexole via Substituted-Benzothiazole Derivatives for Amyotrophic Lateral Sclerosis Disease Treatment: Case Studies.从利鲁唑到通过取代苯并噻唑衍生物治疗肌萎缩侧索硬化症：案例研究。

Molecules. 2020 Jul 22;25(15):3320. doi: 10.3390/molecules25153320.

Rethinking to riluzole mechanism of action: the molecular link among protein kinase CK1δ activity, TDP-43 phosphorylation, and amyotrophic lateral sclerosis pharmacological treatment.重新思考利鲁唑的作用机制：蛋白激酶CK1δ活性、TDP-43磷酸化与肌萎缩侧索硬化症药物治疗之间的分子联系。

Neural Regen Res. 2019 Dec;14(12):2083-2085. doi: 10.4103/1673-5374.262578.

The neuroprotective drug riluzole acts via small conductance Ca2+-activated K+ channels to ameliorate defects in spinal muscular atrophy models.神经保护药物利鲁唑通过小电导钙激活钾通道发挥作用，改善脊髓性肌萎缩模型的缺陷。

J Neurosci. 2013 Apr 10;33(15):6557-62. doi: 10.1523/JNEUROSCI.1536-12.2013.

6-Meth-oxy-1,3-benzothia-zol-2-amine.6-甲氧基-1,3-苯并噻唑-2-胺

Acta Crystallogr Sect E Struct Rep Online. 2012 Jul 1;68(Pt 7):o2240. doi: 10.1107/S1600536812028152. Epub 2012 Jun 30.

Improvement of endothelium-dependent vasodilations by SKA-31 and SKA-20, activators of small- and intermediate-conductance Ca2+ -activated K+ -channels.小电导和中等电导钙激活钾通道激活剂 SKA-31 和 SKA-20 对内皮依赖性血管舒张的改善作用。

Acta Physiol (Oxf). 2011 Sep;203(1):117-26. doi: 10.1111/j.1748-1716.2010.02240.x. Epub 2011 Mar 1.

A review of the neural mechanisms of action and clinical efficiency of riluzole in treating amyotrophic lateral sclerosis: what have we learned in the last decade?回顾力鲁唑治疗肌萎缩侧索硬化症的作用机制和临床疗效：在过去十年中我们学到了什么？

CNS Neurosci Ther. 2011 Feb;17(1):4-31. doi: 10.1111/j.1755-5949.2009.00116.x.

Naphtho[1,2-d]thiazol-2-ylamine (SKA-31), a new activator of KCa2 and KCa3.1 potassium channels, potentiates the endothelium-derived hyperpolarizing factor response and lowers blood pressure.萘并[1,2-d]噻唑-2-胺（SKA-31），一种新型的KCa2和KCa3.1钾通道激活剂，可增强内皮源性超极化因子反应并降低血压。

Mol Pharmacol. 2009 Feb;75(2):281-95. doi: 10.1124/mol.108.051425. Epub 2008 Oct 27.

Centrally acting muscle relaxants in tetanus.破伤风治疗中作用于中枢的肌肉松弛剂。

Br J Pharmacol Chemother. 1961 Dec;17(3):507-18. doi: 10.1111/j.1476-5381.1961.tb01137.x.

The activity of a variety of chemical compounds against experimental tetanus.多种化合物对实验性破伤风的活性。

Br J Pharmacol Chemother. 1958 Sep;13(3):334-8. doi: 10.1111/j.1476-5381.1958.tb00914.x.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验